Verity & Verity’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $38.6M | Buy |
177,401
+2,729
| +2% | +$605K | 2.87% | 3 |
|
|
2025
Q4 | $39.9M | Buy |
174,672
+1,297
| +0.7% | +$295K | 3.1% | 3 |
|
|
2025
Q3 | $40.1M | Buy |
173,375
+1,181
| +0.7% | +$240K | 3.21% | 2 |
|
|
2025
Q2 | $32M | Sell |
172,194
-1,358
| -0.8% | -$252K | 2.75% | 5 |
|
|
2025
Q1 | $36.4M | Buy |
173,552
+1,700
| +1% | +$330K | 3.19% | 2 |
|
|
2024
Q4 | $30.5M | Buy |
171,852
+8,544
| +5% | +$1.57M | 2.79% | 6 |
|
|
2024
Q3 | $32.3M | Buy |
163,308
+1,131
| +0.7% | +$211K | 3.16% | 2 |
|
|
2024
Q2 | $27.8M | Buy |
162,177
+3,122
| +2% | +$517K | 3.03% | 3 |
|
|
2024
Q1 | $29M | Sell |
159,055
-7,376
| -4% | -$1.27M | 3.23% | 2 |
|
|
2023
Q4 | $25.8M | Buy |
166,431
+1,807
| +1% | +$263K | 2.96% | 5 |
|
|
2023
Q3 | $24.5M | Buy |
164,624
+2,821
| +2% | +$414K | 3.07% | 4 |
|
|
2023
Q2 | $21.8M | Buy |
161,803
+16,667
| +11% | +$2.44M | 2.67% | 10 |
|
|
2023
Q1 | $23.1M | Buy |
145,136
+5,178
| +4% | +$792K | 2.95% | 6 |
|
|
2022
Q4 | $22.6M | Buy |
139,958
+5,690
| +4% | +$872K | 2.95% | 4 |
|
|
2022
Q3 | $18M | Buy |
134,268
+3,795
| +3% | +$545K | 2.9% | 3 |
|
|
2022
Q2 | $20M | Sell |
130,473
-221
| -0.2% | -$33.8K | 3.06% | 2 |
|
|
2022
Q1 | $21.2M | Buy |
130,694
+1,557
| +1% | +$226K | 2.94% | 1 |
|
|
2021
Q4 | $17.5M | Buy |
129,137
+26,112
| +25% | +$3.08M | 2.5% | 8 |
|
|
2021
Q3 | $12.1M | Buy |
103,025
+2,836
| +3% | +$324K | 1.81% | 17 |
|
|
2021
Q2 | $11.3M | Sell |
100,189
-197
| -0.2% | -$22.2K | 1.78% | 21 |
|
|
2021
Q1 | $11.4M | Buy |
100,386
+8,733
| +10% | +$934K | 1.84% | 19 |
|
|
2020
Q4 | $9.99M | Buy |
91,653
+9,322
| +11% | +$896K | 1.89% | 18 |
|
|
2020
Q3 | $7.24M | Buy |
82,331
+2,309
| +3% | +$217K | 1.59% | 29 |
|
|
2020
Q2 | $7.83M | Buy |
80,022
+1,998
| +3% | +$176K | 1.87% | 17 |
|
|
2020
Q1 | $5.95M | Buy |
78,024
+14,901
| +24% | +$1.27M | 1.68% | 24 |
|
|
2019
Q4 | $5.59M | Buy |
63,123
+300
| +0.5% | +$24.9K | 1.08% | 39 |
|
|
2019
Q3 | $4.61M | Buy |
62,823
+4,740
| +8% | +$325K | 0.97% | 39 |
|
|
2019
Q2 | $4.22M | Buy |
58,083
+2,287
| +4% | +$180K | 0.92% | 48 |
|
|
2019
Q1 | $4.5M | Buy |
55,796
+4,626
| +9% | +$378K | 1.03% | 40 |
|
|
2018
Q4 | $4.72M | Buy |
51,170
+4,595
| +10% | +$404K | 1.26% | 31 |
|
|
2018
Q3 | $4.41M | Buy |
46,575
+295
| +0.6% | +$28K | 1.06% | 41 |
|
|
2018
Q2 | $4.29M | Buy |
46,280
+620
| +1% | +$60.6K | 1.11% | 40 |
|
|
2018
Q1 | $4.32M | Sell |
45,660
-694
| -1% | -$76.2K | 1.16% | 36 |
|
|
2017
Q4 | $4.48M | Buy |
46,354
+1,152
| +3% | +$109K | 1.21% | 36 |
|
|
2017
Q3 | $4.02M | Buy |
45,202
+1,185
| +3% | +$90.2K | 1.17% | 41 |
|
|
2017
Q2 | $3.19M | Buy |
44,017
+6,570
| +18% | +$442K | 0.98% | 45 |
|
|
2017
Q1 | $2.44M | Buy |
37,447
+5,247
| +16% | +$330K | 0.76% | 47 |
|
|
2016
Q4 | $2.02M | Buy |
32,200
+3,089
| +11% | +$189K | 0.7% | 48 |
|
|
2016
Q3 | $1.84M | Buy |
29,111
+4,875
| +20% | +$316K | 0.67% | 51 |
|
|
2016
Q2 | $1.5M | Buy |
24,236
+4,918
| +25% | +$300K | 0.58% | 56 |
|
|
2016
Q1 | $1.1M | Buy |
19,318
+7,352
| +61% | +$410K | 0.47% | 60 |
|
|
2015
Q4 | $709K | Buy |
+11,966
| New | +$689K | 0.32% | 64 |
|
|
2013
Q4 | – | Sell |
-32,938
| Closed | -$1.47M | – | 70 |
|
|
2013
Q3 | $1.47M | Sell |
32,938
-7,046
| -18% | -$312K | 0.85% | 56 |
|
|
2013
Q2 | $1.65M | Buy |
+39,984
| New | +$1.75M | 1.01% | 56 |
|
Other funds holding ABBV
VCM
VPM
Verity & Verity's ABBV Position: Q1 2026 in Review
Verity & Verity increased its AbbVie (ABBV) stake by 1.6% in Q1 2026, buying an estimated $605K and bringing the position to 177,401 shares worth $38.6M. The position accounts for 2.87% of the portfolio, ranked #3.
Verity & Verity first reported a position in ABBV in Q2 2013 and has held it in 44 quarters since. The position peaked at $40.1M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Verity & Verity held 177,401 shares of AbbVie worth $38.6M as of Q1 2026.
- Verity & Verity bought 2,729 AbbVie shares in Q1 2026, an estimated $605K.
- AbbVie made up 2.87% of Verity & Verity's portfolio in Q1 2026, its #3 holding.
- Verity & Verity first reported a position in AbbVie in Q2 2013 and has held it in 44 quarters since.
- Verity & Verity's AbbVie position peaked at $40.1M in Q3 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Verity & Verity's 13F filing for Q1 2026, filed 15 Apr 2026.